The **Wegovy pill** is a once-daily tablet that contains semaglutide, the same medicine as the weekly Wegovy injection. In June 2026, it became the first GLP-1 tablet licensed for weight loss in the UK. This guide explains what it is, how it works, who it may suit, how to take it, the side effects and what the trial results show.

Key takeaways
- The Wegovy pill is a prescription-only tablet for weight management in adults.
- It contains semaglutide, taken once a day instead of as a weekly injection.
- You take it on an empty stomach, then wait 30 minutes before eating or drinking.
- In the main trial, people lost 13.6% of their body weight on average over 64 weeks.
- At present, it’s only available privately, not on the NHS.
What Is the Wegovy Pill?
The Wegovy pill is a tablet form of semaglutide. Semaglutide belongs to a group of medicines called GLP-1 receptor agonists. These medicines copy a natural hormone, called GLP-1, that your gut releases after you eat.
The MHRA approved Wegovy tablets on 11 June 2026. They’re licensed for adults, alongside a reduced-calorie diet and more physical activity, who have:
- a BMI of 30 or more, or
- a BMI of 27 to 29.9 plus at least one weight-related health problem, such as high blood pressure or type 2 diabetes
Like all GLP-1 medicines, it’s a prescription-only medicine. So, a prescriber must check that it’s safe and suitable for you.
Is it the same as Rybelsus?
No. Rybelsus is another semaglutide tablet, but it’s licensed to treat type 2 diabetes, not for weight loss. Each product has its own doses and instructions. So, the two can’t be swapped.
How the Wegovy Pill Works
Semaglutide works in a few ways to help you eat less.
In the brain
According to the MHRA, semaglutide acts on parts of the brain that control appetite. As a result, it helps you feel fuller for longer. It also reduces hunger and food cravings. Many people find they’re satisfied with smaller portions.
In the stomach
Semaglutide also slows down how quickly your stomach empties. Food therefore stays in your stomach for longer, which adds to the feeling of fullness. This effect can also cause some of the stomach side effects.
Getting the medicine into your body
Semaglutide is a protein-like medicine. Normally, the stomach breaks this type of medicine down. To solve this, each tablet contains an ingredient called salcaprozate sodium. It helps the stomach absorb semaglutide.
However, food, drink and other tablets can block this process. That’s why the instructions for taking the tablet are so strict.
Does it burn fat?
No. It doesn’t speed up your metabolism or act as a stimulant. Instead, it helps you eat less by changing hunger signals. Weight loss then improves other health markers for many people, such as blood sugar and blood pressure.
How to Take the Wegovy Pill
Taking the tablet correctly makes a big difference to how well it works. The patient leaflet says you should:
- take it first thing, after at least 8 hours without food
- swallow it whole with a sip of water, up to 120ml
- not split, crush or chew it
- wait at least 30 minutes before eating, drinking or taking other tablets
Waiting less than 30 minutes lowers how much medicine your body absorbs. For this reason, many people take it as soon as they wake up.
Wegovy pill doses
Treatment starts low and rises slowly, to reduce side effects. Usually, each step lasts at least a month.
| Treatment stage | Daily dose |
|---|---|
| First month | 1.5mg |
| Second month | 4mg |
| Third month | 9mg |
| From month 4 | 25mg |
Only take one tablet a day. Never take two tablets to get a higher dose. If you forget a dose, skip it and take your usual dose the next day.
Our dosage guide explains each step in more detail.
Wegovy Pill Results
The main trial, called OASIS 4, followed 307 adults for 64 weeks. Everyone also followed diet and activity advice. The key results were:
- People on the 25mg tablet lost 13.6% of their body weight on average.
- Those on a dummy tablet lost about 2%.
- People who kept taking the tablet as advised lost 16.6% on average.
- About 3 in 4 people lost at least 5% of their body weight.
- Almost half lost at least 15%.
Results vary from person to person. Also, weight often returns after stopping. To learn more, read our guide to realistic results.
Wegovy Pill Side Effects
Stomach side effects are the most common, especially while the dose is rising. In the OASIS 4 trial:
- nausea affected 46.6% of people on the tablet
- vomiting affected 30.9%
- constipation affected 20.1%
- diarrhoea affected 17.6%
Most of these effects were mild to moderate and settled with time. Still, they led 3.4% of people to stop treatment. Other very common side effects include headache, tiredness and indigestion.
Serious side effects
Rarely, semaglutide can cause serious problems. Get urgent medical help if you have:
- severe tummy pain that won’t go away, which could be pancreatitis
- signs of a serious allergic reaction, such as swelling of the face or trouble breathing
- sudden loss of vision or rapidly worsening eyesight
Also, drink plenty of fluids if you’re being sick or have diarrhoea, to avoid dehydration. Our side effects guide covers how to manage common problems.
Who Shouldn’t Take the Wegovy Pill?
You shouldn’t take it if you’re allergic to semaglutide or any of its ingredients. In addition, it isn’t suitable:
- during pregnancy, or within 2 months of trying for a baby
- while breastfeeding
- for children and teenagers under 18
Your prescriber will also take extra care if you’ve had pancreatitis, gallbladder problems or diabetic eye disease. Severe kidney or liver problems also need careful thought. Tell them about all your medicines, especially levothyroxine, warfarin, insulin or a sulfonylurea.
Wegovy Pill vs the Wegovy Injection
Both contain semaglutide, and both are licensed for weight management. The main differences are how you take them and how they’re absorbed.
| Feature | Wegovy tablets | Wegovy pen |
|---|---|---|
| How often | Once a day | Once a week |
| How it’s taken | By mouth, on an empty stomach | Injection under the skin |
| Maintenance dose | 25mg | 2.4mg (7.2mg in some cases) |
| Storage | Room temperature, in the blister | Fridge before first use |
| NHS availability | Not currently available | Available through specialist services |
According to the product information, absorption from tablets varies more between people than with injections. If you already use the 2.4mg injection, you can switch to the 25mg tablet. In that case, you start the tablet 1 week after your last injection.
Neither form suits everyone. Some people prefer to avoid needles, while others find the daily fasting routine hard. Your prescriber will help you decide which, if any, is right for you.
Is the Wegovy Pill Available in the UK?
Yes, but only privately. The tablets became available through private providers in July 2026, starting with the lower doses. Higher doses followed later in the summer.
The MHRA says the tablet isn’t currently available on the NHS. Any decision on NHS use will follow a NICE evaluation. Our UK availability guide explains the latest position.
Living With Treatment
The Wegovy pill works best alongside healthy habits. So, try to:
- eat balanced meals with plenty of protein, fruit and vegetables
- stay active, including some strength exercises
- drink enough water each day
- keep your follow-up reviews with your prescriber
Your prescriber will review your progress regularly. They’ll check your weight, side effects and how you’re getting on with the daily routine.
Frequently Asked Questions
Is the Wegovy pill a diet pill?
Not in the traditional sense. It’s a prescription medicine that works on appetite hormones, not a stimulant.
Can I drink coffee with the Wegovy pill?
Not straight away. Wait at least 30 minutes after taking the tablet before you have any food or drink, including tea and coffee.
Do I need to keep the Wegovy pill in the fridge?
No. It doesn’t need special temperature storage. However, keep it in the original blister pack to protect it from light and moisture.
How long do I need to take it?
Weight management is usually long term. Your prescriber will review whether treatment is still right for you at each stage.
Are there other weight loss tablets?
Yes. For example, Foundayo (orforglipron) was approved in August 2026. Our guide to new weight loss pills in the UK compares the current options.
Summary
The Wegovy pill offers a daily tablet form of semaglutide for adults living with obesity or overweight. It works by reducing hunger and helping you feel full. To work properly, it must be taken on an empty stomach with a small sip of water. Stomach side effects are common at first, but often settle. At present, it’s only available privately, and a prescriber must decide if it’s suitable for you.
For more on the wider topic, see our overview of weight loss medicines in the UK, our guide to Mounjaro, what Wegovy is and how it works, and our complete GLP-1 guide. You can also read about orforglipron and about lifestyle changes alongside weight loss medicines.
Why Choose CuraPhyx Pharmacy?
CuraPhyx Pharmacy is a UK pharmacy built around safe, professional care. If you’re thinking about Wegovy tablets, this is what you can expect from us:
- First, a qualified pharmacist prescriber reviews every request for a prescription medicine.
- We check your answers, weight and medical history carefully before making any decision.
- Medicines only leave the pharmacy after clinical approval. If treatment isn’t right for you, we’ll explain why and won’t supply it.
- We send approved orders across the UK in discreet packaging.
- Our team is also happy to help with questions at info@curaphyx.co.uk.
You can find out more about how our weight loss service works, including the checks involved, before you decide whether it’s right for you.
Sources and Further Reading
We checked this article against the following sources in October 2026:
- First GLP-1 tablet for weight loss approved in the UK (June 2026) (MHRA)
- Semaglutide tablets for weight management: summary of product characteristics (emc)
- Semaglutide tablets for weight management: patient information leaflet (emc)
- Wharton S et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). N Engl J Med, 2025
- Semaglutide (NHS)
- What you need to know about these medicines (MHRA)
- Orforglipron (Foundayo) authorised in the UK (August 2026) (MHRA)
- Semaglutide for managing overweight and obesity (NICE TA875)
- Calculate your body mass index (BMI) (NHS)
- Yellow Card scheme (MHRA)
This article is for general information only. It doesn’t replace advice from your GP, pharmacist or prescriber. Wegovy and other GLP-1 medicines are prescription-only medicines, so a prescriber must decide whether they’re suitable for you. Always read the patient information leaflet that comes with your medicine. Last reviewed: October 2026.

